HUM Humana Inc. Common Stock
NYSE · Health Care · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Jul 29, 2026HUM Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
HUM Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
| Ex-date | Split | Type |
|---|---|---|
| Aug. 1, 1991 | 3-for-2 | Forward |
| Feb. 1, 1984 | 6-for-5 | Forward |
| Feb. 1, 1983 | 4-for-3 | Forward |
| Feb. 1, 1982 | 3-for-2 | Forward |
About Humana Inc. Common Stock Company overview from Wikipedia
Humana Inc. is an American for-profit health insurance company based in Louisville, Kentucky. In 2024, the company ranked 92 on the Fortune 500 list. It is the fourth largest health insurance provider in the U.S.
History
1961–1983: Nursing homes and hospitals
Lawyers David A. Jones Sr. and Wendell Cherry founded a nursing home company in 1961. The company, known in 1968 as Extendicare Inc., became the largest nursing home company in the United States. In 1972, Jones and Cherry sold the nursing home chain to purchase hospitals. Humana became one of the first two for-profit hospital ventures in the U.S. along with Hospital Corporation of America (HCA).
In 1974, the partners changed the corporate name to Humana Inc. It grew in the following years, both by business and in 1978 through the takeover of American Medicorp Inc., which doubled the company's size, and grew into the world's largest hospital company in the 1980s.
1984–present
As the American health care system changed in the 1980s, "one of its hospitals in Arizona lost a contract with the largest health-maintenance organization in the area [and] Humana created its own health insurance plan."
In 1993, Humana executives spun off hospital operations from health insurance operations to create Galen Health Care. The following year they sold the 73 hospitals of Galen Health Care Inc. to Nashville-based Columbia Hospital Corporation of America for $3.4 billion.
In 1998, one year after Jones had stepped aside as CEO, UnitedHealthcare made an unsuccessful attempt to acquire Humana. Humana pulled out of the acquisition after United stock dropped $2.9 billion in value.
In 2010, Humana returned to providing healthcare services when it bought Texas-based Concentra Inc., which owns urgent-care and physical therapy centers, for $790 million. They went on to sell Concentra again in 2015 for $1 billion.
In July 2015, Aetna announced that it would acquire Humana for $37 billion. However, the U.S. Department of Justice's Antitrust Division alleged the acquisition would be anticompetitive and sued to block the transaction. Following a trial, U.S. district judge John D. Bates of the United States District Court for the District of Columbia agreed and issued an injunction blocking the acquisition. In February 2017, Aetna and Humana cancelled a $34 billion merger agreement after judges ruled against the merger for a second time.
In July 2018, Humana joined two private equity firms in the acquisition of Kindred Healthcare. The deal provided Humana with a 40% stake in the company's home health, hospice and community care businesses, called "Kindred at Home," for approximately $800 million.
In 2021, Susan Diamond, formerly occupying an interim position, was announced to be the new permanent CFO.
In 2024 Humana announced that they would be leaving the Humana Building, which they had occupied since the 1980s, in order to cut costs. Humana said that it planned to consolidate its workforce in its Waterside-Clocktower campus.
In 2026 KFF reported that Humana was the second-largest parent organization for Medicare Advantage by overall enrollment, and that it had the largest growth in that sector that year.
Humana Military Healthcare Services
In 1993, Humana founded Humana Military Healthcare Services (HMHS) as a wholly owned subsidiary. They were awarded their first TRICARE contract in 1995, and began serving military beneficiaries in 1996.
In 2009, HMHS' contract with the military was awarded to United Military and Veterans Services, a subsidiary of UnitedHealth Group. HMHS protested that decision and the Government Accountability Office upheld the protest in late 2009.
Legal campaign against drug price fixing
Humana filed a lawsuit in August 2019, alleging that 37 defendants engaged in a “far-reaching conspiracy” to “blatantly fix the price” of generic drugs. This follows a similar smaller lawsuit from October 2018.
Controversy
In 1987, Humana sued NBC over a story line in the television medical drama St. Elsewhere in which the hospital was to be sold to a for-profit medical corporation and renamed "Ecumena", with subsequent changes to the hospital, both positive and negative, emanating from that change. The company claimed that the program infringed on the Humana trademark. Humana failed to block the airing of the show, but was successful at forcing NBC into showing a disclaimer at the beginning of the September 30 episode saying that the drama had no connection whatsoever with Humana.
On May 30, 1996, Linda Peeno, a physician who was contracted to work for Humana for nine months, testified before Congress as to the downside of managed care. Peeno said she was effectively rewarded by her employer for causing the death of a patient, because it saved the company a half-million dollars. Peeno stated that she felt the "managed care" model was inherently unethical.
In 1999, season one of Michael Moore's TV series The Awful Truth reported on Humana refusing to pay for a diabetic patient with pancreatic failure needing a transplant. The man's policy stated it covered all of his diabetes-related expenses, but another section of the policy stated that it did not cover organ transplants. Moore conducted a fake funeral on the front steps of the Humana building, and three days later Humana changed its policy and authorized the man's treatment.
Michael Moore's 2007 documentary Sicko used the video of Linda Peeno's testimony. On June 28, 2007, Humana declared that Peeno was never a Humana "associate" (permanent, full-time employee), but rather a "part-time contractor." Humana disputed portions of her Congressional testimony by saying that because the patient's healthcare plan did not cover heart transplants, denial of coverage was valid.
On September 21, 2009, the U.S. Dept. of Health and Human Services opened an investigation into Humana for sending flyers to Medicare recipients that the AARP characterized as deceptive. The mail was made to appear to contain official information about Medicare Advantage and prescription drug benefit information, but instead alleged that core Medicare benefits could be cut by the Obama administration's healthcare reform, a claim refuted by John Rother, AARP's executive vice president. Douglas Elmendorf, the head of the Congressional Budget Office (CBO), supported the claim that Medicare benefits could be cut, but his comments were in reference to just one of several congressional bills. CBO estimates of another healthcare reform bill found that changes to premiums would vary. The Centers for Medicare and Medicaid Services instructed Humana to cease all such mailings to Medicare plan members pending an investigation. HHS Secretary Kathleen Sebelius, in a letter to the insurance industry, threatened that bad actors may be excluded from new health insurance markets that were to open in 2014. Senate Republicans pointed out in a letter to Sebelius that a 1997 directive from the Centers for Medicare and Medicaid Services explicitly allowed HMOs to tell members about legislation and urge them to express opinions.
Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | HUM | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | 36.75Y avg ≈23.6 | ≈23.6 | 36.3 | Overvalued | |
| P/S (TTM) | 0.55Y avg ≈0.7 | ≈0.7 | 0.7 | Undervalued | |
| P/B (MRQ) | 4.05Y avg ≈4.6 | ≈4.6 | 3.9 | Fair value | |
| EV / EBITDA | 25.85Y avg ≈19.0 | ≈19.0 | 16.1 | Fair value | |
| Price / FCF (TTM) | 39.65Y avg ≈54.2 | ≈54.2 | · | · | |
| Price / Cash Flow (TTM) | 30.45Y avg ≈29.3 | ≈29.3 | 15.6 | Overvalued | |
| EV / Revenue (TTM) | 0.45Y avg ≈0.6 | ≈0.6 | · | · | |
| EV / FCF (TTM) | 33.55Y avg ≈46.5 | ≈46.5 | · | · | |
| Price / Tangible Book (MRQ) | 4.35Y avg ≈14.5 | ≈14.5 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | HUM | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Operating Margin (TTM) | 1.9%5Y avg ≈3.2% | ≈3.2% | 3.5% | Weak | |
| EBITDA Margin | 2.1%5Y avg ≈3.2% | ≈3.2% | 3.7% | Weak | |
| Pretax Margin (TTM) | 1.1%5Y avg ≈2.7% | ≈2.7% | 2.8% | Weak | |
| Net Profit Margin (TTM) | 0.88%5Y avg ≈2.2% | ≈2.2% | 2.9% | Weak | |
| ROA (TTM) | 2.4%5Y avg ≈4.9% | ≈4.9% | 3.0% | Weak | |
| ROE (TTM) | 6.8%5Y avg ≈13.3% | ≈13.3% | 10.1% | Weak | |
| ROIC | 7.4%5Y avg ≈9.7% | ≈9.7% | 8.0% | Weak |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | HUM | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Debt / Equity (MRQ) | 0.65Y avg ≈0.7 | ≈0.7 | 0.7 | Low debt | |
| Current Ratio (MRQ) | 1.75Y avg ≈1.7 | ≈1.7 | 1.7 | Strong liquidity | |
| Quick Ratio (MRQ) | 1.35Y avg ≈1.3 | ≈1.3 | 1.3 | In line | |
| Long-Term Debt / Equity (MRQ) | 0.65Y avg ≈0.7 | ≈0.7 | 0.7 | Low debt |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | HUM | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | 10.1%5Y avg ≈11.0% | ≈11.0% | · | · | |
| Revenue CAGR 3Y | 11.8%5Y avg ≈11.8% | ≈11.8% | · | · | |
| Revenue CAGR 5Y | 10.9% | · | · | · | |
| EPS YoY | -1.4%5Y avg ≈-14.8% | ≈-14.8% | · | · | |
| Net Income YoY | -1.6%5Y avg ≈-16.3% | ≈-16.3% | · | · | |
| EPS CAGR 3Y | -23.6%5Y avg ≈-18.4% | ≈-18.4% | · | · | |
| EPS CAGR 5Y | -17.2% | · | · | · | |
| Net Income CAGR 3Y | -24.9%5Y avg ≈-20.0% | ≈-20.0% | · | · | |
| Net Income CAGR 5Y | -18.8% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | HUM | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 2.75Y avg ≈2.4 | ≈2.4 | 2.4 | In line | |
| Receivables Turnover | 43.45Y avg ≈52.0 | ≈52.0 | 16.3 | Top tier | |
| Revenue / Employee | ≈$1.9M | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Dividends Yield, payout ratio, dividend history, 5Y CAGR
| Ex-date | Amount | Currency | Yield |
|---|---|---|---|
| Jun 26, 2026 | $0.89 | USD | ≈0.92% |
| Mar 27, 2026 | $0.89 | USD | ≈2.1% |
| Dec 26, 2025 | $0.89 | USD | ≈1.4% |
| Sep 26, 2025 | $0.89 | USD | ≈1.4% |
| Jun 27, 2025 | $0.89 | USD | ≈1.5% |
| Mar 28, 2025 | $0.89 | USD | ≈1.3% |
| Dec 31, 2024 | $0.89 | USD | ≈1.4% |
| Sep 30, 2024 | $0.89 | USD | ≈1.1% |
| Jun 28, 2024 | $0.89 | USD | ≈0.95% |
| Mar 27, 2024 | $0.89 | USD | ≈1.0% |
| Dec 28, 2023 | $0.89 | USD | ≈0.78% |
| Sep 28, 2023 | $0.89 | USD | ≈0.70% |
| Jun 29, 2023 | $0.89 | USD | ≈0.75% |
| Mar 30, 2023 | $0.89 | USD | ≈0.67% |
| Dec 29, 2022 | $0.79 | USD | ≈0.61% |
| Sep 29, 2022 | $0.79 | USD | ≈0.62% |
| Jun 29, 2022 | $0.79 | USD | ≈0.64% |
| Mar 30, 2022 | $0.79 | USD | ≈0.66% |
| Dec 30, 2021 | $0.70 | USD | ≈0.60% |
| Sep 29, 2021 | $0.70 | USD | ≈0.69% |
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Jul 29, 2026 | $7.61 | $7.29 | 4.3% |
| March 31, 2026 | $10.31 | $10.29 | 0.21% | |
| Dec. 31, 2025 | $-3.96 | $-4.05 | 2.1% | |
| Sept. 30, 2025 | $3.24 | $2.85 | 13.8% | |
| June 30, 2025 | $6.27 | $5.98 | 4.9% | |
| March 31, 2025 | $11.58 | $10.17 | 13.9% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $129.66B | $117.76B | $106.37B | $92.87B | $83.06B | $77.16B | $64.89B | $56.91B | $53.77B | $54.38B | $54.29B | $48.50B | |
| SG&A Expense | $15.45B | $13.70B | $13.19B | $12.67B | $10.12B | $10.05B | $7.38B | $7.53B | $6.57B | $7.17B | $7.29B | $7.64B | |
| Operating Income | $2.70B | $2.56B | $4.01B | $3.80B | $3.15B | $4.99B | $3.19B | $3.10B | $4.26B | $1.74B | $2.35B | $2.36B | |
| Interest Expense | · | · | $493M | $401M | $326M | $283M | $242M | $218M | $242M | $189M | $186M | $192M | |
| Other Non-op | $-451M | $-181M | $-137M | $-68M | $532M | $-103M | $506M | $-33M | $0 | $0 | · | · | |
| Pretax Income | $1.44B | $1.62B | $3.33B | $3.57B | $3.42B | $4.67B | $3.47B | $2.07B | $4.02B | $1.55B | $2.43B | $2.17B | |
| Income Tax | $250M | $413M | $836M | $762M | $485M | $1.31B | $763M | $391M | $1.57B | $938M | $1.16B | $1.02B | |
| Net Income | $1.19B | $1.21B | $2.49B | $2.81B | $2.93B | $3.37B | $2.71B | $1.68B | $2.45B | $614M | $1.28B | $1.15B | |
| EPS (Basic) | $9.87 | $10.01 | $20.09 | $22.20 | $22.79 | $25.47 | $20.20 | $12.24 | $16.94 | $4.11 | $8.54 | $7.44 | |
| EPS (Diluted) | $9.84 | $9.98 | $20.00 | $22.08 | $22.67 | $25.31 | $20.10 | $12.16 | $16.81 | $4.07 | $8.44 | $7.36 | |
| Shares (Basic) | 120,454,000 | 120,571,000 | 123,866,000 | 126,419,000 | 128,688,000 | 132,199,000 | 134,055,000 | 137,486,000 | 144,493,000 | 149,375,000 | 149,455,000 | 154,187,000 | |
| Shares (Diluted) | 120,826,000 | 120,869,000 | 124,441,000 | 127,094,000 | 129,396,000 | 133,012,000 | 134,727,000 | 138,403,000 | 145,585,000 | 150,917,000 | 151,142,000 | 155,874,000 | |
| EBITDA | $2.70B | $2.56B | $4.01B | $3.80B | $3.15B | $4.99B | $3.19B | $3.10B | $4.26B | $1.74B | $2.35B | $2.36B |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.20B | $2.22B | $4.69B | $5.06B | $3.39B | $4.67B | $4.05B | $2.34B | $4.04B | $3.88B | $2.57B | $1.94B | |
| Short-term Investments | $15.70B | $18.21B | $16.63B | $13.88B | $13.19B | $12.55B | $10.97B | · | · | · | · | · | |
| Receivables | $3.27B | $2.70B | $2.04B | $1.67B | $1.81B | $1.14B | $1.06B | $1.01B | $854M | $1.28B | $1.16B | $1.05B | |
| Other Current Assets | $9.56B | $6.68B | $6.63B | $5.57B | $6.49B | $5.28B | $3.81B | $3.56B | $2.95B | $3.44B | $4.71B | $4.01B | |
| Current Assets | $32.73B | $29.82B | $29.99B | $26.18B | $24.89B | $23.64B | $19.89B | $16.95B | $17.40B | $16.19B | $15.71B | $15.54B | |
| PP&E (Net) | $2.23B | $2.53B | $3.03B | $3.22B | $3.07B | $2.37B | $1.96B | $1.74B | $1.58B | $1.50B | $1.38B | $1.23B | |
| PP&E (Gross) | $5.52B | $5.67B | $5.88B | $6.36B | $5.95B | $5.49B | $4.62B | $4.05B | $3.56B | $3.19B | $2.72B | $2.91B | |
| Accum. Depreciation | $3.29B | $3.14B | $2.85B | $3.14B | $2.87B | $3.12B | $2.66B | $2.31B | $1.98B | $1.69B | $1.34B | $1.68B | |
| Goodwill | $9.69B | $9.63B | $9.55B | $9.14B | $11.09B | $4.45B | $3.93B | $3.90B | $3.28B | $3.27B | $3.27B | $3.23B | |
| Intangibles | $1.13B | $1.44B | $1.69B | $1.76B | $2.64B | $329M | $177M | $245M | $226M | $280M | $357M | $440M | |
| Other Non-current Assets | $3.13B | $3.38B | $3.38B | $3.38B | $4.38B | $2.13B | $1.83B | $1.38B | $2.17B | $2.23B | $2.48B | $1.58B | |
| Total Assets | $48.91B | $46.48B | $47.06B | $43.05B | $44.36B | $34.97B | $29.07B | $25.41B | $27.18B | $25.40B | $24.68B | $23.53B | |
| Accounts Payable | $5.72B | $5.26B | $6.57B | $5.24B | $4.51B | $4.01B | $3.75B | $3.07B | $4.07B | $2.47B | $2.21B | $2.10B | |
| Short-term Debt | · | · | · | · | · | · | · | $1.69B | $150M | $300M | $299M | $0 | |
| Current Liabilities | $16.35B | $16.94B | $18.87B | $17.18B | $15.33B | $13.39B | $10.93B | $10.08B | $9.41B | $7.82B | $8.15B | $7.47B | |
| Capital Leases | $418M | $392M | $444M | $456M | $546M | $355M | $332M | · | · | · | · | · | |
| Other Non-current Liabilities | $2.46B | $1.95B | $1.66B | $1.47B | $2.38B | $1.79B | $1.14B | $581M | $237M | $263M | $235M | $236M | |
| Total Liabilities | $31.17B | $30.03B | $30.75B | $27.68B | $28.25B | $21.24B | $17.04B | $15.25B | $17.34B | $14.71B | $14.33B | $13.88B | |
| Total Debt | $12.37B | $11.14B | $10.21B | $9.03B | $10.54B | $6.06B | $4.97B | $6.07B | $4.92B | $4.09B | $4.12B | $3.83B | |
| Common Stock | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | |
| Retained Earnings | $29.07B | $28.32B | $27.54B | $25.49B | $23.09B | $20.52B | $17.48B | $15.07B | $13.67B | $11.45B | $11.02B | $9.92B | |
| Treasury Stock | $14.42B | $14.37B | $13.66B | $12.16B | $10.16B | $9.92B | $8.46B | $7.32B | $6.33B | $3.30B | $3.29B | $2.86B | |
| AOCI | $-633M | $-1.07B | $-999M | $-1.30B | $42M | $391M | $156M | $-159M | $19M | $-66M | $58M | $223M | |
| Stockholders' Equity | $17.66B | $16.38B | $16.26B | $15.31B | $16.08B | $13.73B | $12.04B | $10.16B | $9.84B | $10.69B | $10.35B | $9.65B | |
| Liabilities + Equity | $48.91B | $46.48B | $47.06B | $43.05B | $44.36B | $34.97B | $29.07B | $25.41B | $27.18B | $25.40B | $24.68B | $23.53B | |
| Shares Outstanding | 198,719,000 | 198,719,000 | 198,690,000 | 198,667,000 | 198,649,000 | 198,649,000 | 198,630,000 | · | · | · | · | · |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $698M | $839M | $779M | $709M | $596M | · | · | $444M | $410M | $388M | $354M | $328M | |
| Stock-based Comp | $241M | $207M | $175M | $216M | $180M | $181M | $163M | $137M | $157M | $115M | $109M | $98M | |
| Deferred Tax | $75M | $-192M | $-164M | $-100M | $15M | $195M | $162M | $194M | $132M | $-71M | $-2M | $-64M | |
| Amort. of Intangibles | $51M | $60M | $67M | $81M | $65M | $88M | $70M | $90M | $75M | $77M | $93M | $121M | |
| Restructuring | · | · | · | · | · | · | $47M | · | $148M | · | · | · | |
| Operating Cash Flow | $921M | $2.97B | $3.98B | $4.59B | $2.26B | $5.64B | $5.28B | $2.17B | $4.05B | $1.94B | $868M | $1.62B | |
| CapEx | $546M | $575M | $1.00B | $1.14B | $1.34B | $964M | $736M | $612M | $524M | $527M | $523M | $528M | |
| Investing Cash Flow | $2.27B | $-2.95B | $-3.49B | $-1.01B | $-6.56B | $-3.06B | $-1.28B | $-3.09B | $-2.94B | $-1.36B | $320M | $-63M | |
| Net Debt Issued | · | · | · | · | · | · | $-400M | $0 | $-800M | $0 | $0 | $-500M | |
| Stock Repurchased | $151M | $817M | $1.57B | $2.10B | $79M | $1.82B | $1.07B | $1.09B | $3.37B | $104M | $385M | $872M | |
| Net Stock Activity | $-151M | $-817M | $-1.57B | $-2.10B | $-79M | $-1.82B | $-1.07B | $-1.09B | $-3.37B | $-104M | $-385M | $-872M | |
| Dividends Paid | $430M | $431M | $431M | $392M | $354M | $323M | $291M | $265M | $220M | $177M | $172M | $172M | |
| Financing Cash Flow | $-1.22B | $-2.49B | $-856M | $-1.91B | $3.02B | $-1.96B | $-2.29B | $-785M | $-945M | $732M | $-552M | $-758M | |
| Net Change in Cash | $1.98B | $-2.47B | $-367M | $1.67B | $-1.28B | $619M | $1.71B | $-1.70B | $165M | $1.31B | $636M | $797M | |
| Taxes Paid | · | $570M | $997M | $758M | $227M | $1.13B | $518M | $631M | $1.50B | $916M | $1.18B | $1.03B | |
| Free Cash Flow | $375M | $2.39B | $2.98B | $3.47B | $946M | $4.67B | $4.55B | $1.56B | $3.52B | $1.41B | $345M | $1.09B | |
| Levered FCF | · | · | $2.61B | $3.15B | $666M | $4.47B | $4.36B | $1.38B | $3.38B | $1.33B | $247M | $989M |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 2.1% | 2.2% | 3.8% | 4.1% | 3.8% | 6.5% | 4.9% | 5.5% | 7.9% | 3.2% | 4.3% | 4.9% | |
| Net Margin | 0.92% | 1.0% | 2.3% | 3.0% | 3.5% | 4.4% | 4.2% | 3.0% | 4.5% | 1.1% | 2.4% | 2.4% | |
| Pretax Margin | 1.1% | 1.5% | 3.1% | 3.8% | 4.1% | 6.1% | 5.3% | 3.6% | 7.5% | 2.9% | 4.5% | 4.5% | |
| EBITDA Margin | 2.1% | 2.2% | 3.8% | 4.1% | 3.8% | 6.5% | 4.9% | 5.5% | 7.9% | 3.2% | 4.3% | 4.9% | |
| ROA | 2.5% | 2.6% | 5.5% | 6.4% | 7.4% | 10.5% | 9.9% | 6.4% | 9.3% | 2.5% | 5.3% | 5.2% | |
| ROE | 7.0% | 7.4% | 15.8% | 18.2% | 18.1% | 22.8% | 22.9% | 16.2% | 23.3% | 5.8% | 12.8% | 12.1% | |
| ROIC | 7.4% | 7.1% | 11.3% | 12.3% | 10.1% | 18.1% | 14.6% | 15.5% | 17.6% | 4.7% | 8.5% | 9.3% |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.0 | 1.8 | 1.6 | 1.5 | 1.6 | 1.8 | 1.8 | 1.7 | 1.9 | 2.1 | 1.9 | 2.0 | |
| Quick Ratio | 1.4 | 1.4 | 1.2 | 1.2 | 1.2 | 1.4 | 0.5 | 0.3 | 0.5 | 0.7 | 0.5 | 0.4 | |
| Debt / Equity | 0.7 | 0.7 | 0.6 | 0.6 | 0.7 | 0.4 | 0.4 | 0.6 | 0.5 | 0.4 | 0.4 | 0.4 | |
| LT Debt / Equity | 0.7 | 0.7 | 0.6 | 0.6 | 0.7 | 0.4 | 0.4 | 0.4 | 0.5 | 0.4 | 0.4 | 0.4 | |
| Interest Coverage | · | · | 8.1 | 9.5 | 9.7 | 17.6 | 13.2 | 14.2 | 17.6 | 9.2 | 12.6 | 12.3 |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 2.7 | 2.5 | 2.4 | 2.1 | 2.1 | 2.4 | 2.4 | 2.2 | 2.0 | 2.2 | 2.3 | 2.2 | |
| Receivables Turnover | 43.4 | 49.7 | 57.4 | 53.3 | 56.3 | 70.3 | 62.7 | 60.9 | 50.4 | 44.6 | 49.0 | 45.8 |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $88.85 | $82.40 | $81.85 | $77.07 | · | · | · | · | · | · | · | · | |
| Revenue / Share | $1073.15 | $974.29 | $854.81 | $730.72 | $641.94 | $580.06 | $481.63 | $411.20 | $369.32 | $360.32 | $359.19 | $311.15 | |
| Cash Flow / Share | $7.62 | $24.54 | $31.99 | $36.09 | $17.48 | $42.39 | $39.22 | $15.70 | $27.83 | $12.83 | $5.74 | $10.38 | |
| Cash / Share | $21.14 | $11.18 | $23.62 | $25.47 | · | · | · | · | · | · | · | · | |
| Dividend / Share | · | · | · | · | · | · | · | · | · | $1.16 | $1.15 | $1.11 | |
| Dividend Paid / Share | $3.54 | $3.54 | $3.44 | $3.06 | $2.73 | $2.43 | $2.15 | $1.90 | $1.49 | $1.16 | $1.14 | $1.10 | |
| EPS (TTM) | $9.84 | $9.98 | $20.00 | $22.08 | $22.67 | $25.31 | $20.10 | $12.16 | $16.81 | $4.07 | $8.44 | $7.36 |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 10.1% | 10.7% | 14.5% | 11.8% | 7.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 11.8% | 12.3% | 11.3% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 10.9% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -1.4% | -50.1% | -9.4% | -2.6% | -10.4% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -23.6% | -23.9% | -7.5% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -17.2% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -1.6% | -51.5% | -11.3% | -4.3% | -12.9% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -24.9% | -25.6% | -9.6% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -18.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | 5.9% | · | · | · | · | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $129.66B | $117.76B | $106.37B | $92.87B | $83.06B | $77.16B | $64.89B | $56.91B | $53.77B | $54.38B | $54.29B | $48.50B | |
| Net Income TTM | $1.19B | $1.21B | $2.49B | $2.81B | $2.93B | $3.37B | $2.71B | $1.68B | $2.45B | $614M | $1.28B | $1.15B | |
| Market Cap | $50.90B | $50.42B | $90.96B | $101.76B | · | · | · | · | · | · | · | · | |
| Enterprise Value | $43.36B | $41.13B | $79.86B | $91.85B | · | · | · | · | · | · | · | · | |
| P/E | 26.0 | 25.4 | 22.9 | 23.2 | 20.5 | 16.2 | 18.2 | 23.6 | 14.8 | 50.1 | 21.2 | 19.5 | |
| P/S | 0.4 | 0.4 | 0.9 | 1.1 | · | · | · | · | · | · | · | · | |
| P/B | 2.9 | 3.1 | 5.6 | 6.6 | · | · | · | · | · | · | · | · | |
| P / Tangible Book | 7.4 | 9.5 | 18.1 | 23.1 | · | · | · | · | · | · | · | · | |
| P / Cash Flow | 55.3 | 17.0 | 22.8 | 22.2 | · | · | · | · | · | · | · | · | |
| P / FCF | 135.7 | 21.1 | 30.6 | 29.3 | · | · | · | · | · | · | · | · | |
| EV / EBITDA | 16.0 | 16.1 | 19.9 | 24.2 | · | · | · | · | · | · | · | · | |
| EV / FCF | 115.6 | 17.2 | 26.8 | 26.5 | · | · | · | · | · | · | · | · | |
| EV / Revenue | 0.3 | 0.3 | 0.8 | 1.0 | · | · | · | · | · | · | · | · | |
| Dividend Yield | 0.84% | 0.85% | 0.47% | 0.39% | · | · | · | · | · | · | · | · | |
| Earnings Yield | 3.8% | 3.9% | 4.4% | 4.3% | 4.9% | 6.2% | 5.5% | 4.2% | 6.8% | 2.0% | 4.7% | 5.1% | |
| Payout Ratio | 36.2% | 35.7% | 17.3% | 14.0% | 12.1% | 9.6% | 10.8% | 15.8% | 9.0% | 28.8% | 13.5% | 15.0% | |
| Annual Payout | $430M | $431M | $431M | $392M | $354M | $323M | $291M | $265M | $220M | $177M | $172M | $172M |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $40.87B | $39.65B | $32.52B | $32.65B | $32.39B | $32.11B | $29.21B | $29.40B | $29.54B | $29.61B | $26.46B | $26.42B | $26.75B | $26.74B | $22.44B | $22.80B | |
| SG&A Expense | $3.98B | $4.02B | $4.44B | $4.08B | $3.55B | $3.38B | $4.17B | $3.34B | $3.15B | $3.04B | $3.83B | $3.27B | $3.11B | $2.98B | $3.55B | $3.06B | |
| Operating Income | $1.36B | $1.75B | $-808M | $400M | $1.10B | $2.01B | $-543M | $728M | $1.14B | $1.24B | $-348M | $1.21B | $1.44B | $1.72B | $124M | $1.17B | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $159M | · | $114M | $120M | $113M | · | $102M | |
| Other Non-op | $-211M | $34M | $-53M | $-35M | $-200M | $-163M | $-155M | $92M | $-55M | $-63M | $-97M | $6M | $-54M | $8M | $-84M | $-13M | |
| Pretax Income | $952M | $1.59B | $-1.13B | $134M | $741M | $1.69B | $-963M | $651M | $918M | $1.01B | $-610M | $1.09B | $1.25B | $1.60B | $-72M | $1.30B | |
| Income Tax | $238M | $395M | $-249M | $-86M | $179M | $406M | $-216M | $155M | $223M | $251M | $-75M | $256M | $296M | $359M | $-58M | $107M | |
| Net Income | $694M | $1.19B | $-796M | $195M | $545M | $1.24B | $-693M | $480M | $679M | $741M | $-541M | $832M | $959M | $1.24B | $-15M | $1.20B | |
| EPS (Basic) | $5.78 | $9.85 | $-6.58 | $1.62 | $4.52 | $10.31 | $-5.74 | $3.99 | $5.63 | $6.13 | $-4.26 | $6.74 | $7.70 | $9.91 | $-0.07 | $9.45 | |
| EPS (Diluted) | $5.73 | $9.83 | $-6.59 | $1.62 | $4.51 | $10.30 | $-5.73 | $3.98 | $5.62 | $6.11 | $-4.24 | $6.71 | $7.66 | $9.87 | $-0.08 | $9.39 | |
| Shares (Basic) | 120,066,000 | 120,332,000 | · | 120,273,000 | 120,539,000 | 120,666,000 | · | 120,405,000 | 120,445,000 | 120,978,000 | · | 123,426,000 | 124,574,000 | 125,005,000 | · | 126,572,000 | |
| Shares (Diluted) | 121,135,000 | 120,652,000 | · | 120,745,000 | 120,745,000 | 120,844,000 | · | 120,764,000 | 120,665,000 | 121,268,000 | · | 123,983,000 | 125,109,000 | 125,564,000 | · | 127,356,000 | |
| EBITDA | $1.36B | $1.75B | · | $400M | $1.10B | $2.01B | · | $728M | $1.14B | $1.24B | · | $1.21B | $1.44B | $1.72B | · | $1.17B |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $6.89B | $4.95B | $4.20B | $5.39B | $4.04B | $4.25B | $2.22B | $5.12B | $5.50B | $5.91B | · | $15.15B | $16.21B | $13.73B | · | $13.56B | |
| Short-term Investments | $16.98B | $17.01B | $15.70B | $16.74B | $17.67B | $17.89B | $18.21B | $19.03B | $17.42B | $16.70B | · | $15.14B | $15.25B | $14.93B | · | $13.12B | |
| Receivables | $5.70B | $5.22B | $3.27B | $2.68B | $4.50B | $4.46B | $2.70B | $2.14B | $4.09B | $3.92B | · | $1.82B | $1.43B | $3.11B | · | $1.61B | |
| Other Current Assets | $10.52B | $10.90B | $9.56B | $7.94B | $7.40B | $7.83B | $6.68B | $6.63B | $5.84B | $6.26B | · | $6.14B | $5.87B | $5.76B | · | $5.42B | |
| Current Assets | $40.09B | $38.08B | $32.73B | $32.75B | $33.62B | $34.42B | $29.82B | $32.93B | $32.86B | $32.80B | · | $38.25B | $38.76B | $37.53B | · | $33.71B | |
| PP&E (Net) | $2.10B | $2.17B | $2.23B | $2.27B | $2.36B | $2.43B | $2.53B | $2.69B | $2.82B | $2.98B | · | $3.34B | $3.31B | $3.23B | · | $3.22B | |
| PP&E (Gross) | · | · | $5.52B | · | · | · | $5.67B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $3.29B | · | · | · | $3.14B | · | · | · | · | · | · | · | · | · | |
| Goodwill | $10.48B | $10.49B | $9.69B | $9.62B | $9.63B | $9.63B | $9.63B | $9.59B | $9.57B | $9.56B | $9.55B | $9.54B | $9.54B | $9.32B | $9.14B | $9.10B | |
| Intangibles | $1.18B | $1.19B | $1.13B | $1.23B | $1.38B | $1.43B | $1.44B | $1.65B | $1.66B | $1.68B | · | $1.76B | $1.78B | $1.75B | · | $1.80B | |
| Other Non-current Assets | $3.25B | $3.28B | $3.13B | $4.02B | $3.69B | $3.38B | $3.38B | $3.67B | $3.72B | $3.64B | · | $3.64B | $3.73B | $3.58B | · | $3.63B | |
| Total Assets | $57.20B | $55.28B | $48.91B | $49.72B | $50.36B | $50.93B | $46.48B | $50.01B | $50.09B | $50.09B | · | $55.91B | $56.45B | $54.78B | · | $50.77B | |
| Accounts Payable | $7.26B | $6.53B | $5.72B | $5.52B | $5.59B | $5.38B | $5.26B | $5.92B | $6.53B | $6.50B | · | $7.60B | $8.12B | $7.43B | · | $6.77B | |
| Current Liabilities | $23.01B | $21.51B | $16.35B | $16.18B | $17.22B | $18.04B | $16.94B | $18.73B | $19.79B | $19.69B | · | $27.82B | $28.28B | $26.94B | · | $25.05B | |
| Capital Leases | · | · | $418M | · | · | · | $392M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $2.93B | $2.85B | $2.46B | $2.35B | $2.26B | $2.34B | $1.95B | $1.77B | $1.83B | $1.83B | · | $1.59B | $1.56B | $1.46B | · | $1.60B | |
| Total Liabilities | $37.92B | $36.63B | $31.17B | $31.14B | $32.06B | $33.11B | $30.03B | $32.38B | $33.37B | $33.91B | · | $38.90B | $39.56B | $38.14B | · | $34.45B | |
| Total Debt | $11.98B | $12.27B | · | $12.61B | $12.59B | $12.73B | · | $11.89B | $11.75B | $12.39B | · | $9.48B | $9.72B | $9.74B | · | $7.80B | |
| Common Stock | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | · | $33M | $33M | $33M | · | $33M | |
| Retained Earnings | $30.74B | $30.15B | $29.07B | $29.98B | $29.89B | $29.45B | $28.32B | $29.12B | $28.75B | $28.17B | · | $28.19B | $27.47B | $26.62B | · | $25.61B | |
| Treasury Stock | $14.51B | $14.52B | $14.42B | $14.46B | $14.46B | $14.36B | $14.37B | $14.40B | $14.40B | $14.36B | · | $13.13B | $12.75B | $12.22B | · | $11.15B | |
| AOCI | $-751M | $-731M | $-633M | $-666M | $-783M | $-868M | $-1.07B | $-653M | $-1.12B | $-1.09B | · | $-1.50B | $-1.23B | $-1.11B | · | $-1.47B | |
| Stockholders' Equity | $19.21B | $18.58B | $17.66B | $18.52B | $18.23B | $17.75B | $16.38B | $17.57B | $16.67B | $16.13B | · | $16.95B | $16.83B | $16.58B | · | $16.32B | |
| Liabilities + Equity | $57.20B | $55.28B | $48.91B | $49.72B | $50.36B | $50.93B | $46.48B | $50.01B | $50.09B | $50.09B | · | $55.91B | $56.45B | $54.78B | · | $50.77B | |
| Shares Outstanding | 198,720,000 | 198,720,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,691,000 | 198,690,000 | 198,690,000 | 198,690,000 | 198,667,000 | 198,667,000 | 198,667,000 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $159M | $163M | $164M | $173M | $178M | $183M | $208M | $210M | $212M | $209M | $201M | $201M | $191M | $186M | · | · | |
| Stock-based Comp | $65M | $51M | $48M | $83M | $61M | $49M | $54M | $53M | $55M | $45M | $33M | $53M | $51M | $38M | $43M | $80M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | $-164M | $0 | · | · | $-67M | $-200M | |
| Amort. of Intangibles | $8M | $11M | $8M | $13M | $15M | $15M | $14M | $15M | $15M | $16M | $16M | $17M | $16M | $18M | $20M | $25M | |
| Operating Cash Flow | $1.97B | $1.25B | $-1.65B | $971M | $1.27B | $331M | $-528M | $1.86B | $1.21B | $423M | $-7.13B | $1.25B | $3.18B | $6.69B | $-5.13B | $8.45B | |
| CapEx | $132M | $121M | $202M | $135M | $114M | $95M | $154M | $130M | $114M | $177M | $283M | $234M | $264M | $223M | $275M | $288M | |
| Investing Cash Flow | $-273M | $-2.55B | $632M | $980M | $347M | $314M | $-63M | $-1.47B | $-1.00B | $-414M | $-882M | $-585M | $-733M | $-1.29B | $-1.01B | $1.68B | |
| Debt Issued | $0 | $990M | · | · | $0 | $1.48B | · | · | · | · | · | · | · | · | · | · | |
| Net Debt Issued | · | $980M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Stock Repurchased | $1M | $107M | $42M | $0 | $100M | $9M | $49M | $2M | $49M | $717M | $571M | $379M | $529M | $94M | $1.06B | $4M | |
| Net Stock Activity | · | $-107M | · | · | · | $-9M | · | · | · | $-717M | · | · | · | $-94M | · | · | |
| Dividends Paid | $107M | $107M | $109M | $107M | $106M | $108M | $108M | $107M | $107M | $109M | $111M | $109M | $111M | $100M | $101M | $100M | |
| Financing Cash Flow | $249M | $2.05B | $-168M | $-603M | $-1.83B | $1.38B | $-2.30B | $-770M | $-620M | $1.21B | $-2.44B | $-1.73B | $36M | $3.28B | $-2.36B | $-1.79B | |
| Net Change in Cash | $1.94B | $751M | $-1.19B | $1.35B | $-210M | $2.03B | $-2.90B | $-385M | $-409M | $1.22B | $-10.45B | $-1.07B | $2.48B | $8.67B | $-8.50B | $8.34B | |
| Taxes Paid | $148M | $-7M | · | $122M | $41M | $-12M | · | $208M | $361M | $1M | · | $276M | $675M | $6M | $7M | $378M | |
| Free Cash Flow | · | $1.13B | · | · | · | $236M | · | · | · | $246M | · | · | · | $6.46B | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $127M | · | · | · | $6.38B | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 3.3% | 4.4% | · | 1.2% | 3.4% | 6.3% | · | 2.5% | 3.9% | 4.2% | · | 4.6% | 5.4% | 6.4% | · | 5.1% | |
| Net Margin | 1.7% | 3.0% | · | 0.60% | 1.7% | 3.9% | · | 1.6% | 2.3% | 2.5% | · | 3.1% | 3.6% | 4.6% | · | 5.2% | |
| Pretax Margin | 2.3% | 4.0% | · | 0.41% | 2.3% | 5.3% | · | 2.2% | 3.0% | 3.3% | · | 4.1% | 4.7% | 6.0% | · | 5.7% | |
| EBITDA Margin | 3.3% | 4.4% | · | 1.2% | 3.4% | 6.3% | · | 2.5% | 3.9% | 4.2% | · | 4.6% | 5.4% | 6.4% | · | 5.1% | |
| ROA | 1.3% | 2.2% | · | 0.39% | 1.1% | 2.5% | · | 0.91% | 1.3% | 1.4% | · | 1.6% | 1.9% | 2.5% | · | 2.5% | |
| ROE | 3.7% | 6.5% | · | 1.1% | 3.1% | 7.3% | · | 2.8% | 4.0% | 4.5% | · | 5.0% | 5.9% | 7.8% | · | 7.3% | |
| ROIC | 3.3% | 4.3% | · | 2.1% | 2.7% | 5.0% | · | 1.9% | 3.0% | 3.2% | · | 3.5% | 4.1% | 5.1% | · | 4.5% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.8 | · | 2.0 | 2.0 | 1.9 | · | 1.8 | 1.7 | 1.7 | · | 1.4 | 1.4 | 1.4 | · | 1.3 | |
| Quick Ratio | 1.3 | 1.3 | · | 1.5 | 1.5 | 1.5 | · | 1.4 | 1.4 | 1.3 | · | 1.2 | 1.2 | 1.2 | · | 1.1 | |
| Debt / Equity | 0.6 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.8 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | |
| LT Debt / Equity | 0.6 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.8 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 7.8 | · | 10.6 | 12.0 | 15.2 | · | 11.5 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.7 | · | 0.7 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | |
| Receivables Turnover | 8.0 | 8.2 | · | 13.5 | 7.5 | 7.7 | · | 14.8 | 10.7 | 8.4 | · | 15.4 | 11.1 | 8.5 | · | 13.1 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $96.68 | $93.50 | · | $93.21 | $91.76 | $89.33 | · | $88.39 | $83.89 | $81.18 | · | $85.30 | $84.72 | $83.44 | · | $82.13 | |
| Revenue / Share | $337.37 | $328.61 | · | $270.40 | $268.23 | $265.73 | · | $243.43 | $244.81 | $244.18 | · | $213.12 | $213.79 | $212.98 | · | $179.02 | |
| Cash Flow / Share | · | $10.39 | · | · | · | $2.74 | · | · | · | $3.49 | · | · | · | $53.26 | · | · | |
| Cash / Share | $34.69 | $24.91 | · | $27.11 | $20.33 | $21.39 | · | $25.74 | $27.68 | $29.74 | · | $76.24 | $81.60 | $69.14 | · | $68.24 | |
| Dividend / Share | $0.89 | $0.89 | $0.89 | · | · | $0.89 | $0.89 | · | · | · | · | · | · | · | · | · | |
| Dividend Paid / Share | $0.89 | $0.89 | $0.89 | $0.89 | $0.89 | $0.89 | $0.89 | $0.89 | $0.89 | $0.89 | · | · | · | · | · | · | |
| EPS (TTM) | $10.59 | $9.37 | · | $10.70 | $13.06 | $14.17 | · | $11.47 | $14.20 | $16.24 | · | $24.16 | $26.84 | $24.66 | · | $22.05 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $145.68B | $137.20B | · | $126.36B | $123.11B | $120.26B | · | $115.01B | $112.04B | $109.24B | · | $102.35B | $98.73B | $95.64B | · | $91.48B | |
| Net Income TTM | $1.28B | $1.13B | · | $1.29B | $1.58B | $1.71B | · | $1.36B | $1.71B | $1.99B | · | $3.02B | $3.38B | $3.12B | · | $2.81B | |
| Market Cap | $78.94B | $34.46B | · | $51.70B | $48.58B | $52.58B | · | $62.94B | $74.25B | $68.89B | · | $96.67B | $88.84B | $96.44B | · | $96.39B | |
| Enterprise Value | $67.04B | $24.77B | · | $42.18B | $39.46B | $43.17B | · | $50.68B | $63.07B | $58.67B | · | $75.86B | $67.10B | $77.52B | · | $77.51B | |
| P/E | 37.5 | 18.5 | · | 24.3 | 18.7 | 18.7 | · | 27.6 | 26.3 | 21.3 | · | 20.1 | 16.7 | 19.7 | · | 22.0 | |
| P/S | 0.5 | 0.3 | · | 0.4 | 0.4 | 0.4 | · | 0.5 | 0.7 | 0.6 | · | 0.9 | 0.9 | 1.0 | · | 1.1 | |
| P/B | 4.1 | 1.9 | · | 2.8 | 2.7 | 3.0 | · | 3.6 | 4.5 | 4.3 | · | 5.7 | 5.3 | 5.8 | · | 5.9 | |
| P / Tangible Book | 10.5 | 5.0 | · | 6.7 | 6.7 | 7.9 | · | 10.0 | 13.6 | 14.1 | · | 17.1 | 16.1 | 17.5 | · | 17.8 | |
| P / Cash Flow | · | 27.5 | · | · | · | 158.9 | · | · | · | 162.9 | · | · | · | 14.4 | · | · | |
| EV / Revenue | 0.5 | 0.2 | · | 0.3 | 0.3 | 0.4 | · | 0.4 | 0.6 | 0.5 | · | 0.7 | 0.7 | 0.8 | · | 0.8 | |
| Dividend Yield | 0.54% | 1.2% | · | 0.83% | 0.88% | 0.82% | · | 0.69% | 0.59% | 0.64% | · | 0.44% | 0.46% | 0.42% | · | 0.40% | |
| Earnings Yield | 2.7% | 5.4% | · | 4.1% | 5.3% | 5.4% | · | 3.6% | 3.8% | 4.7% | · | 5.0% | 6.0% | 5.1% | · | 4.5% | |
| Payout Ratio | · | 9.0% | · | · | · | 8.7% | · | · | · | 14.7% | · | · | · | 8.1% | · | · | |
| Annual Payout | $430M | $429M | · | $429M | $429M | $430M | · | $434M | $436M | $440M | · | $421M | $412M | $401M | · | $382M |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $129.66B | $117.76B | $106.37B | $92.87B | $83.06B |
| Operating Margin % | 2.1% | 2.2% | 3.8% | 4.1% | 3.8% |
| Net Income | $1.19B | $1.21B | $2.49B | $2.81B | $2.93B |
| Diluted EPS | $9.84 | $9.98 | $20.00 | $22.08 | $22.67 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debt / Equity | 0.7 | 0.7 | 0.6 | 0.6 | 0.7 |
| Current Ratio | 2.0 | 1.8 | 1.6 | 1.5 | 1.6 |
| Quick Ratio | 1.4 | 1.4 | 1.2 | 1.2 | 1.2 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $375M | $2.39B | $2.98B | $3.47B | $946M |
Institutional owners (13F) 1,038 filers · $52.7B total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 248 (+126 vs prior Q) | 85 (-76 vs prior Q) | 325 (+68 vs prior Q) | 288 (-56 vs prior Q) | +3.9M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Dodge & Cox | $4,345,737,744 | 10,940,380 | 8.25% | Shares |
| BlackRock, Inc. | $4,138,159,785 | 10,417,803 | 7.85% | Shares |
| VANGUARD GROUP INC | $3,652,890,202 | 14,261,860 | 6.93% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $3,115,642,737 | 7,843,620 | 5.91% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2,311,405,702 | 5,818,956 | 4.39% | Shares |
| STATE STREET CORP | $2,172,441,313 | 5,457,072 | 4.12% | Shares |
| PZENA INVESTMENT MANAGEMENT LLC | $1,749,013,682 | 4,403,136 | 3.32% | Shares |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $1,664,784,292 | 3,578,245 | 3.16% | Shares |
| EAGLE CAPITAL MANAGEMENT LLC | $1,528,010,749 | 3,846,762 | 2.90% | Shares |
| Sessa Capital IM, L.P. | $1,480,732,883 | 3,727,740 | 2.81% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $1,337,386,742 | 3,369,757 | 2.54% | Shares |
| JPMORGAN CHASE & CO | $1,257,951,102 | 3,234,637 | 2.39% | Shares |
| FMR LLC | $1,157,405,236 | 2,913,763 | 2.20% | Shares |
| Capital International Investors | $950,462,637 | 2,392,826 | 1.80% | Shares |
| GOLDMAN SACHS GROUP INC | $913,562,254 | 2,299,889 | 1.73% | Shares |
| NAYA CAPITAL MANAGEMENT UK LTD | $728,407,339 | 1,833,763 | 1.38% | Shares |
| NORGES BANK | $694,505,009 | 1,748,414 | 1.32% | Shares |
| Invesco Ltd. | $587,403,999 | 1,478,788 | 1.11% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $544,521,489 | 1,370,831 | 1.03% | Shares |
| MORGAN STANLEY | $535,876,914 | 1,349,066 | 1.02% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $445,839,059 | 1,122,669 | 0.85% | Shares |
| Capital Research Global Investors | $443,462,035 | 1,116,990 | 0.84% | Shares |
| NORTHERN TRUST CORP | $442,978,948 | 1,115,198 | 0.84% | Shares |
| Slate Path Capital LP | $428,969,795 | 1,079,930 | 0.81% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $423,436,520 | 1,066,000 | 0.80% | Put option |
| Capital World Investors | $406,119,738 | 1,022,425 | 0.77% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $399,841,652 | 1,006,600 | 0.76% | Call option |
| Newport Trust Company, LLC | $384,768,345 | 968,653 | 0.73% | Shares |
| CITADEL ADVISORS LLC | $363,376,856 | 914,800 | 0.69% | Call option |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $348,908,912 | 878,377 | 0.66% | Shares |
| Legal & General Group Plc | $329,760,125 | 830,170 | 0.63% | Shares |
| BARROW HANLEY MEWHINNEY & STRAUSS LLC | $314,921,577 | 792,814 | 0.60% | Shares |
| CITADEL ADVISORS LLC | $310,904,094 | 782,700 | 0.59% | Put option |
| Allianz Asset Management GmbH | $307,098,329 | 773,119 | 0.58% | Shares |
| WELLINGTON MANAGEMENT GROUP LLP | $304,014,312 | 765,355 | 0.58% | Shares |
| BANK OF AMERICA CORP /DE/ | $279,490,113 | 703,615 | 0.53% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $267,791,027 | 674,163 | 0.51% | Shares |
| Maple Rock Capital Partners Inc. | $249,553,862 | 628,251 | 0.47% | Shares |
| Diamond Hill Capital Management, LLC (Investment Advisor) | $245,555,446 | 618,185 | 0.47% | Shares |
| Bank of New York Mellon Corp | $238,144,113 | 599,527 | 0.45% | Shares |
| GOLDMAN SACHS GROUP INC | $232,333,978 | 584,900 | 0.44% | Call option |
| MARSHALL WACE, LLP | $216,873,381 | 545,978 | 0.41% | Shares |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $189,649,820 | 1,093,776 | 0.36% | Shares |
| CITADEL ADVISORS LLC | $178,360,519 | 449,022 | 0.34% | Shares |
| High Ground Investment Management LLP | $177,941,848 | 447,968 | 0.34% | Shares |
| 1832 Asset Management L.P. | $176,401,430 | 444,090 | 0.33% | Shares |
| BCV Asset Management Inc. | $173,695,656 | 445,719 | 0.33% | Shares |
| Nuveen, LLC | $167,646,743 | 422,051 | 0.32% | Shares |
| Holocene Advisors, LP | $165,040,541 | 415,489 | 0.31% | Shares |
| DEUTSCHE BANK AG\ | $163,345,207 | 411,221 | 0.31% | Shares |
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| David A. Jones ×2 filings | Nov. 12, 2003 | · | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 79 insiders · 48 officers · 29 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| James A. Rechtin | President & CEO | May 1, 2026 A | 63,938 | 0 | 0 | $0 |
| Bruce D Broussard | Chief Executive Officer | Feb. 21, 2024 A | 110,130 | 0 | 0 | $0 |
| Celeste Mellet | Chief Financial Officer | May 1, 2026 A | 39,637 | 0 | 0 | $0 |
| Susan M Diamond | Chief Financial Officer | Dec. 31, 2024 J | 20,165 | 0 | 0 | $0 |
| Brian A Kane | Chief Financial Officer | Feb. 22, 2021 A | 24,342 | 0 | 0 | $0 |
| Steven E Mcculley | Interim CFO & Treasurer | May 9, 2014 G | 14,916 | 0 | 0 | $0 |
| Aaron Martin | President, Medicare Advantage | May 1, 2026 A | 25,237 | 0 | 0 | $0 |
| David Dintenfass | President, Enterprise Growth | May 1, 2026 A | 25,407 | 0 | 0 | $0 |
| Sanjay K Shetty | President, CenterWell | May 1, 2026 A | 22,088 | 1 | 0 | $150,012 |
| George Renaudin II | President, Insurance | March 31, 2026 J | 16,075 | 0 | 0 | $0 |
| M.D. Andrew C. Agwunobi, | Seg. President, Home Solutions | Feb. 24, 2023 A | 182 | 0 | 0 | $0 |
| Timothy Alan Wheatley | Segment President, Retail | Dec. 15, 2022 M | 3,983 | 0 | 0 | $0 |
| Joseph William Jasser | Seg. President, Care Delivery | Dec. 15, 2017 M | 222 | 0 | 0 | $0 |
| Thomas J Liston | President - Retail Segment | Feb. 18, 2014 A | 105,443 | 0 | 0 | $0 |
| James E Murray | EVP & COO | March 31, 2017 J | 34,668 | 0 | 0 | $0 |
| Shantanu Nundy | Chief Medical Officer | Sept. 1, 2026 A | 2,549 | 0 | 0 | $0 |
| Japan Mehta | Chief Information Officer | May 1, 2026 A | 17,176 | 0 | 0 | $0 |
| Michelle A. O'Hara | Chief Human Resources Officer | May 1, 2026 A | 20,026 | 0 | 0 | $0 |
| Joseph C Ventura | Chief Legal Officer | May 1, 2026 A | 27,405 | 0 | 0 | $0 |
| John-Paul W. Felter | SVP, Chief Accting Off & Cont. | Feb. 24, 2026 F | 7,484 | 0 | 0 | $0 |
| Vishal Agrawal | Chief Strat & Corp Dev Officer | Feb. 24, 2025 A | 16,717 | 0 | 0 | $0 |
| Timothy S. Huval | Chief Administrative Officer | Dec. 31, 2024 G | 7,111 | 0 | 0 | $0 |
| Samir Deshpande | Chief Information Officer | Dec. 15, 2024 M | 14,015 | 0 | 0 | $0 |
| William Kevin Fleming | Chief Corporate Aff. Officer | Feb. 21, 2024 A | 11,723 | 0 | 0 | $0 |
| Susan D. Schick | Seg Pres. Grp. & Military Bus. | Feb. 24, 2023 F | 3,687 | 0 | 0 | $0 |
| William H Shrank | Chief Medical Officer | May 1, 2022 M | 4,294 | 0 | 0 | $0 |
| Cynthia H Zipperle | SVP, Chief Acct Officer & Cont | March 22, 2022 J | 5,723 | 0 | 0 | $0 |
| Heather Cox | Chief Dig Health & Analyt Off. | Feb. 25, 2022 F | 6,014 | 0 | 0 | $0 |
| Christopher H. Hunter | Seg Pres. Gr. & Military Bus. | March 16, 2021 G | 8,168 | 0 | 0 | $0 |
| Elizabeth D Bierbower | Strategic Advisor | Dec. 18, 2019 M | 18,092 | 0 | 0 | $0 |
| Brian P. Leclaire | Strategic Advisor | Dec. 15, 2019 M | 6,339 | 0 | 0 | $0 |
| Jody L Bilney | Chief Consumer Officer | Feb. 25, 2019 A | 9,774 | 0 | 0 | $0 |
| Roy A Beveridge, | Chief Medical Officer | Feb. 19, 2019 M | 10,791 | 0 | 0 | $0 |
| Todoroff M Christopher | Chief Legal Officer | Dec. 15, 2018 M | 11,136 | 0 | 0 | $0 |
| Heidi S Margulis | Chief Corp. Affairs Officer | Dec. 15, 2018 M | 6,476 | 0 | 0 | $0 |
| Christopher E Kay | SVP & Chief Innovation Officer | March 17, 2017 M | 4,361 | 0 | 0 | $0 |
| Tim S Mcclain | Group Pres, Govt & Other Busin | Feb. 18, 2014 A | 1,101 | 0 | 0 | $0 |
| Bruce D Perkins | Sgmt Pres, Healthcare Services | Feb. 18, 2014 A | 15,946 | 0 | 0 | $0 |
| Paul B. K. Kusserow | Sr VP & Ch Strat Dev Officer | June 24, 2013 M | 19,347 | 0 | 0 | $0 |
| HATHCOCK BONNIE C | Sr VP & Chief Human Res. Off | Dec. 24, 2012 G | 2,287 | 0 | 0 | $0 |
| Venkata R Madabhushi | SVP & Chief Innov & Mrkting Of | April 28, 2012 F | 11,946 | 0 | 0 | $0 |
| GOODMAN BRUCE J | Sr. VP | Feb. 23, 2012 A | 23,280 | 0 | 0 | $0 |
| Jonathan T Lord MD | Sr VP & Chief Innovation Off. | Feb. 4, 2009 I | 0 | 0 | 0 | $0 |
| Arthur P Hipwell | Senior Vice President | March 27, 2008 J | 302 | 0 | 0 | $0 |
| Kathleen Pellegrino | VP and Acting General Counsel | Feb. 25, 2008 F | 13,836 | 0 | 0 | $0 |
| Steven O Moya | Sr. VP-Chief Marketing Officer | Dec. 31, 2007 I | 0 | 0 | 0 | $0 |
| John M Bertko | Vice President & Chief Actuary | Feb. 23, 2007 M | 57,548 | 0 | 0 | $0 |
| Eugene R Shields | Senior Vice President-Gov Prgm | Jan. 6, 2005 M | 0 | 0 | 0 | $0 |
| Kurt J Hilzinger | Director | Sept. 30, 2026 A | 19,448 | 0 | 0 | $0 |
| Paul John Smith | Director | Aug. 1, 2026 A | 544 | 0 | 0 | $0 |
| Robert Stuart Field | Director | May 1, 2026 A | 852 | 0 | 0 | $0 |
| Jorge S. Mesquita | Director | Jan. 2, 2026 A | 4,127 | 0 | 0 | $0 |
| Frank A Damelio | Director | Jan. 2, 2026 A | 20,634 | 0 | 0 | $0 |
| Raquel C. Bono | Director | Dec. 31, 2025 A | 397 | 0 | 0 | $0 |
| Wayne A.I. Frederick | Director | Dec. 31, 2025 A | 440 | 0 | 0 | $0 |
| Marcy S Klevorn | Director | Dec. 31, 2025 A | 436 | 0 | 0 | $0 |
| John W Garratt | Director | Dec. 31, 2025 A | 1,685 | 0 | 0 | $0 |
| David T Feinberg | Director | Dec. 31, 2025 A | 1,207 | 0 | 0 | $0 |
| Karen Katz | Director | Dec. 31, 2025 A | 590 | 0 | 0 | $0 |
| Brad D Smith | Director | Dec. 31, 2024 A | 1,169 | 0 | 0 | $0 |
| William J. Mcdonald | Director | Jan. 2, 2024 A | 2,276 | 0 | 0 | $0 |
| JONES DAVID A JR/KY | Director | Feb. 28, 2023 G | 32,440 | 0 | 0 | $0 |
| OBRIEN JAMES J /KY | Director | Jan. 3, 2023 A | 1,794 | 0 | 0 | $0 |
| Marissa T Peterson | Director | Jan. 3, 2022 A | 2,044 | 0 | 0 | $0 |
| Frank Bisignano | Director | Jan. 4, 2021 A | 2,727 | 0 | 0 | $0 |
| Webster Roy Dunbar | Director | Dec. 31, 2019 A | 2,880 | 0 | 0 | $0 |
| Karen B Desalvo | Director | Jan. 2, 2019 A | 634 | 0 | 0 | $0 |
| David Nash | Director | Jan. 2, 2019 A | 112 | 0 | 0 | $0 |
| William Mitchell | Director | Dec. 31, 2018 A | 688 | 0 | 0 | $0 |
| Michael B Mccallister | Director | Dec. 31, 2013 M | 113,885 | 0 | 0 | $0 |
| Ann W Reynolds | Director | May 15, 2011 M | 39,727 | 0 | 0 | $0 |
| James O Robbins | Director | Jan. 3, 2007 A | · | 0 | 0 | $0 |
| HALL JOHN R /KY | Director | Jan. 3, 2006 A | 22,423 | 0 | 0 | $0 |
| JONES DAVID A SR/KY | Director | April 5, 2005 G | 4,777,524 | 0 | 0 | $0 |
| Michael E Gellert | Director | Jan. 3, 2005 A | 60,237 | 0 | 0 | $0 |
| Irwin Lerner | Director | Jan. 2, 2004 A | 30,637 | 0 | 0 | $0 |
| Frederick John Crawford | · | Aug. 1, 2026 A | 544 | 0 | 0 | $0 |
| Gordon Smith | · | Dec. 31, 2025 A | 765 | 0 | 0 | $0 |
| James H Bloem | · | Nov. 7, 2013 M | 30,326 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 143 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| IHF · iShares Trust | 4.63% | 151,582 SH | Sept. 11, 2026 | Daily |
| FMTM · EA Series Trust | 3.07% | 21,303 NS | July 31, 2026 | N-PORT |
| TGLB · T. Rowe Price Exchange-Traded Funds… | 2.57% | 1,854 NS | July 31, 2026 | N-PORT |
| RPV · Invesco Exchange-Traded Fund Trust | 2.35% | 103,450 SH | Oct. 2, 2026 | Daily |
| SRHQ · Elevation Series Trust | 2.31% | 13,473 NS | July 31, 2026 | N-PORT |
| EPMV · Harbor ETF Trust | 1.75% | 225 NS | July 31, 2026 | N-PORT |
| CVAR · ETF Opportunities Trust | 1.71% | 2,014 NS | July 31, 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1.57% | 35,951 SH | Oct. 2, 2026 | Daily |
| NUMV · Nushares ETF Trust | 1.39% | 16,939 NS | July 31, 2026 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 1.16% | 290 NS | July 31, 2026 | N-PORT |
| FVAL · FIDELITY COVINGTON TRUST | 0.88% | 32,276 NS | July 31, 2026 | N-PORT |
| VOE · VANGUARD INDEX FUNDS | 0.82% | 771,237 SH | Aug. 19, 2026 | Daily |
| IYH · iShares Trust | 0.78% | 70,303 SH | Sept. 11, 2026 | Daily |
| JOET · Virtus ETF Trust II | 0.74% | 4,940 NS | July 31, 2026 | N-PORT |
| PALC · Pacer Funds Trust | 0.74% | 4,248 NS | July 31, 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 0.71% | 181,374 SH | Oct. 2, 2026 | Daily |
| VHT · VANGUARD WORLD FUND | 0.70% | 360,880 SH | Aug. 19, 2026 | Daily |
| PDP · Invesco Exchange-Traded Fund Trust | 0.70% | 27,208 SH | Oct. 2, 2026 | Daily |
| FHLC · FIDELITY COVINGTON TRUST | 0.63% | 57,108 NS | July 31, 2026 | N-PORT |
| IXJ · iShares Trust | 0.61% | 63,215 SH | Sept. 11, 2026 | Daily |
| CURE · Direxion Shares ETF Trust | 0.50% | 2,362 NS | July 31, 2026 | N-PORT |
| IWS · iShares Trust | 0.47% | 179,478 SH | Sept. 11, 2026 | Daily |
| VO · VANGUARD INDEX FUNDS | 0.46% | 2,601,869 SH | Aug. 19, 2026 | Daily |
| IMCV · iShares Trust | 0.40% | 11,586 SH | Sept. 11, 2026 | Daily |
| MTUM · iShares Trust | 0.37% | 227,558 SH | Sept. 11, 2026 | Daily |
| IWR · iShares Trust | 0.35% | 492,212 SH | Sept. 11, 2026 | Daily |
| PRF · Invesco Exchange-Traded Fund Trust | 0.34% | 88,063 SH | Oct. 2, 2026 | Daily |
| IMCB · iShares Trust | 0.34% | 14,123 SH | Sept. 11, 2026 | Daily |
| VRP · Invesco Exchange-Traded Fund Trust … | 0.33% | 10,420,000 | Oct. 2, 2026 | Daily |
| FFLC · FIDELITY COVINGTON TRUST | 0.32% | 10,722 NS | July 31, 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0.32% | 8,116 SH | Oct. 2, 2026 | Daily |
| IMCG · iShares Trust | 0.27% | 27,157 SH | Sept. 11, 2026 | Daily |
| XOEF · iShares Trust | 0.27% | 151 SH | Sept. 11, 2026 | Daily |
| VLUE · iShares Trust | 0.26% | 62,879 SH | Sept. 11, 2026 | Daily |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0.25% | 320,000 | Oct. 2, 2026 | Daily |
| SIZE · iShares Trust | 0.24% | 2,599 SH | Sept. 11, 2026 | Daily |
| BSCS · Invesco Exchange-Traded Self-Indexe… | 0.23% | 8,027,000 | Oct. 2, 2026 | Daily |
| ROUS · Lattice Strategies Trust | 0.23% | 4,462 NS | July 31, 2026 | N-PORT |
| BSCR · Invesco Exchange-Traded Self-Indexe… | 0.22% | 9,983,000 | Oct. 2, 2026 | Daily |
| EUSA · iShares, Inc. | 0.22% | 10,324 SH | Sept. 11, 2026 | Daily |
| HELO · J.P. Morgan Exchange-Traded Fund Tr… | 0.21% | 26,395 NS | July 31, 2026 | N-PORT |
| CATH · Global X Funds | 0.21% | 7,419 NS | July 31, 2026 | N-PORT |
| VYM · VANGUARD WHITEHALL FUNDS | 0.20% | 479,438 SH | Aug. 19, 2026 | Daily |
| RSP · Invesco Exchange-Traded Fund Trust | 0.19% | 487,833 SH | Oct. 2, 2026 | Daily |
| EVUS · iShares Trust | 0.19% | 1,842 SH | Sept. 11, 2026 | Daily |
| USXF · iShares Trust | 0.19% | 7,125 SH | Sept. 11, 2026 | Daily |
| ESMV · iShares Trust | 0.19% | 37 SH | Sept. 11, 2026 | Daily |
| SUSA · iShares Trust | 0.19% | 19,078 SH | Sept. 11, 2026 | Daily |
| ACVF · ETF Opportunities Trust | 0.19% | 790 NS | July 31, 2026 | N-PORT |
| VTV · VANGUARD INDEX FUNDS | 0.18% | 1,140,642 SH | Aug. 19, 2026 | Daily |
| DFLV · Dimensional ETF Trust | 0.18% | 32,943 NS | July 31, 2026 | N-PORT |
| JVAL · J.P. Morgan Exchange-Traded Fund Tr… | 0.17% | 3,921 NS | July 31, 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0.17% | 3,648 SH | Aug. 19, 2026 | Daily |
| DFSU · Dimensional ETF Trust | 0.17% | 10,472 NS | July 31, 2026 | N-PORT |
| IVE · iShares Trust | 0.16% | 200,080 SH | Sept. 11, 2026 | Daily |
| VOOV · VANGUARD ADMIRAL FUNDS | 0.16% | 27,648 SH | Aug. 19, 2026 | Daily |
| IUSV · iShares Trust | 0.15% | 104,740 SH | Sept. 11, 2026 | Daily |
| VEGN · ETF Series Solutions | 0.15% | 709 NS | July 31, 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0.14% | 60,086 NS | July 31, 2026 | N-PORT |
| SUSL · iShares Trust | 0.14% | 4,238 SH | Sept. 11, 2026 | Daily |
| FYEE · Fidelity Greenwood Street Trust | 0.14% | 839 NS | July 31, 2026 | N-PORT |
| DSI · iShares Trust | 0.14% | 18,418 SH | Sept. 11, 2026 | Daily |
| IQSU · New York Life Investments ETF Trust | 0.14% | 1,230 NS | July 31, 2026 | N-PORT |
| CHRI · Global X Funds | 0.13% | 29 NS | July 31, 2026 | N-PORT |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0.13% | 72,504 SH | Aug. 19, 2026 | Daily |
| IWD · iShares Trust | 0.13% | 267,199 SH | Sept. 11, 2026 | Daily |
| BSCT · Invesco Exchange-Traded Self-Indexe… | 0.12% | 3,809,000 | Oct. 2, 2026 | Daily |
| NULV · Nushares ETF Trust | 0.11% | 6,797 NS | July 31, 2026 | N-PORT |
| ESGU · iShares Trust | 0.11% | 47,962 SH | Sept. 11, 2026 | Daily |
| DGRO · iShares Trust | 0.10% | 111,232 SH | Sept. 11, 2026 | Daily |
| EGLE · Global X Funds | 0.10% | 6 NS | July 31, 2026 | N-PORT |
| GLBL · Pacer Funds Trust | 0.10% | 3 NS | July 31, 2026 | N-PORT |
| LQAI · Exchange Listed Funds Trust | 0.10% | 6 NS | July 31, 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0.09% | 1,886 SH | Oct. 2, 2026 | Daily |
| TOPC · iShares Trust | 0.09% | 72 SH | Sept. 11, 2026 | Daily |
| ILCV · iShares Trust | 0.08% | 2,783 SH | Sept. 11, 2026 | Daily |
| XVV · iShares Trust | 0.08% | 1,375 SH | Sept. 11, 2026 | Daily |
| VV · VANGUARD INDEX FUNDS | 0.08% | 140,219 SH | Aug. 19, 2026 | Daily |
| ESGV · VANGUARD WORLD FUND | 0.08% | 27,152 SH | Aug. 19, 2026 | Daily |
| QVML · Invesco Exchange-Traded Fund Trust … | 0.08% | 3,447 SH | Oct. 2, 2026 | Daily |
| DFAC · Dimensional ETF Trust | 0.08% | 100,648 NS | July 31, 2026 | N-PORT |
| XTR · Global X Funds | 0.08% | 10 NS | July 31, 2026 | N-PORT |
| IVV · iShares Trust | 0.07% | 1,513,176 SH | Sept. 11, 2026 | Daily |
| ILCB · iShares Trust | 0.07% | 2,328 SH | Sept. 11, 2026 | Daily |
| XCLR · Global X Funds | 0.07% | 7 NS | July 31, 2026 | N-PORT |
| VOO · VANGUARD INDEX FUNDS | 0.07% | 3,119,147 SH | Aug. 19, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.07% | 3,812,375 SH | Aug. 19, 2026 | Daily |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0.07% | 19,809 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.07% | 10,113 SH | Aug. 19, 2026 | Daily |
| PBP · Invesco Exchange-Traded Fund Trust | 0.07% | 715 SH | Oct. 2, 2026 | Daily |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0.07% | 20,848 SH | Oct. 2, 2026 | Daily |
| IYY · iShares Trust | 0.07% | 5,172 SH | Sept. 11, 2026 | Daily |
| IWB · iShares Trust | 0.07% | 82,919 SH | Sept. 11, 2026 | Daily |
| XYLD · Global X Funds | 0.07% | 6,091 NS | July 31, 2026 | N-PORT |
| PTLC · Pacer Funds Trust | 0.07% | 6,112 NS | July 31, 2026 | N-PORT |
| BBUS · J.P. Morgan Exchange-Traded Fund Tr… | 0.07% | 16,615 NS | July 31, 2026 | N-PORT |
| USCL · iShares Trust | 0.07% | 4,768 SH | Sept. 11, 2026 | Daily |
| VOTE · TCW ETF Trust | 0.07% | 2,035 NS | July 31, 2026 | N-PORT |
| BKLC · BNY Mellon ETF Trust | 0.07% | 10,127 NS | July 31, 2026 | N-PORT |
| XRMI · Global X Funds | 0.07% | 92 NS | July 31, 2026 | N-PORT |
| IWV · iShares Trust | 0.07% | 33,101 SH | Sept. 11, 2026 | Daily |
| ITOT · iShares Trust | 0.07% | 156,223 SH | Sept. 11, 2026 | Daily |
| LRGF · iShares Trust | 0.06% | 5,842 SH | Sept. 11, 2026 | Daily |
| DXUV · Dimensional ETF Trust | 0.06% | 959 NS | July 31, 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.06% | 36,333 NS | July 31, 2026 | N-PORT |
| XYLG · Global X Funds | 0.06% | 111 NS | July 31, 2026 | N-PORT |
| SPUU · Direxion Shares ETF Trust | 0.06% | 453 NS | July 31, 2026 | N-PORT |
| ILCG · iShares Trust | 0.06% | 4,804 SH | Sept. 11, 2026 | Daily |
| QDPL · Pacer Funds Trust | 0.06% | 2,883 NS | July 31, 2026 | N-PORT |
| TOV · EA Series Trust | 0.06% | 454 NS | July 31, 2026 | N-PORT |
| TILT · FlexShares Trust | 0.06% | 3,564 NS | July 31, 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.06% | 20,053 NS | July 31, 2026 | N-PORT |
| PHDG · Invesco Actively Managed Exchange-T… | 0.06% | 95 SH | Oct. 2, 2026 | Daily |
| VOXP · Advisors Series Trust | 0.06% | 9 NS | July 31, 2026 | N-PORT |
| TOK · iShares Trust | 0.06% | 333 SH | Sept. 11, 2026 | Daily |
| HCMT · Direxion Shares ETF Trust | 0.05% | 835 NS | July 31, 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.05% | 4,948 NS | July 31, 2026 | N-PORT |
| URTH · iShares, Inc. | 0.05% | 10,772 SH | Sept. 11, 2026 | Daily |
| SPXL · Direxion Shares ETF Trust | 0.05% | 9,382 NS | July 31, 2026 | N-PORT |
| ACWI · iShares Trust | 0.05% | 38,539 SH | Sept. 11, 2026 | Daily |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.04% | 196,805 SH | Aug. 19, 2026 | Daily |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0.04% | 4,718 SH | Oct. 2, 2026 | Daily |
| NEAR · iShares U.S. ETF Trust | 0.03% | 1,504,000 SH | Sept. 11, 2026 | Daily |
| GLOF · iShares Trust | 0.02% | 106 SH | Sept. 11, 2026 | Daily |
| DYNF · BlackRock ETF Trust | 0.01% | 14,919 SH | Sept. 11, 2026 | Daily |
| CRBN · iShares Trust | 0.01% | 383 SH | Sept. 11, 2026 | Daily |
| VXUS · VANGUARD STAR FUNDS | 0.00% | 4,397,881 SH | Aug. 19, 2026 | Daily |
| VPL · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.00% | 401,850 SH | Aug. 19, 2026 | Daily |
| VSS · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.00% | 932,492 SH | Aug. 19, 2026 | Daily |
| VEA · VANGUARD TAX-MANAGED FUNDS | 0.00% | 2,391,019 SH | Aug. 19, 2026 | Daily |
| VSGX · VANGUARD WORLD FUND | 0.00% | 54,062 SH | Aug. 19, 2026 | Daily |
| BIV · VANGUARD BOND INDEX FUNDS | · | · | July 15, 2026 | Daily |
| BLV · VANGUARD BOND INDEX FUNDS | · | · | July 15, 2026 | Daily |
| BSV · VANGUARD BOND INDEX FUNDS | · | · | July 15, 2026 | Daily |
| BND · VANGUARD BOND INDEX FUNDS | · | · | July 15, 2026 | Daily |
| VUSB · VANGUARD BOND INDEX FUNDS | · | · | July 15, 2026 | Daily |
| VPLS · VANGUARD MALVERN FUNDS | · | · | July 15, 2026 | Daily |
| VCSH · VANGUARD SCOTTSDALE FUNDS | · | · | July 15, 2026 | Daily |
| VCIT · VANGUARD SCOTTSDALE FUNDS | · | · | July 15, 2026 | Daily |
| VCLT · VANGUARD SCOTTSDALE FUNDS | · | · | July 15, 2026 | Daily |
| VTC · VANGUARD SCOTTSDALE FUNDS | · | · | July 30, 2026 | Daily |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | July 30, 2026 | Daily |
| VCEB · VANGUARD WORLD FUND | · | · | July 30, 2026 | Daily |
HUM Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
12-Month Price Target
23 analysts · 2026-09-30Mean target $423.74 +9.1%
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| HUM | $50.90B | 26.0 | 10.1% | 0.92% | 7.0% | · |
| UNH | $299.08B | 25.0 | 11.8% | 2.7% | 12.0% | · |
| ELV | $77.37B | 13.9 | 12.5% | 2.8% | 13.3% | · |
| CNC | $20.24B | -3.0 | 19.4% | -3.4% | -28.8% | 7.3% |
| MOH | $8.85B | 19.5 | 11.8% | 1.0% | 10.9% | · |
| HQY | $7.12B | 34.0 | 9.5% | 16.4% | 10.1% | 69.5% |
| CLOV | · | -5.1 | 40.3% | -4.5% | -26.2% | · |
| PGNY | $2.14B | 39.5 | 10.4% | 4.5% | 11.3% | 23.6% |
| ALHC | $4.03B | · | 46.1% | -0.02% | -0.52% | · |
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.